Temasek

Temasek ramping up focus on cybersecurity assets

The Singaporean state investor remains on the lookout for promising cybersecurity assets to complement its existing platform and provide more than just healthy investment returns.
August 21, 2019

Temasek nets $506m from Intouch stake sale

Singapore’s sovereign wealth fund cuts its stake in the holding company of Thailand’s largest carrier, potentially bringing an end to the saga surrounding the controversial investment.
August 15, 2019

Trade war pushes private equity into SE Asia

As the China-US trade war gives global markets the jitters, private equity firms are increasingly looking to Southeast Asian countries like Indonesia for a return.
January 17, 2019

Gene sequencing company raises $200m

With the debate about gene-edited babies raging, it is a sensitive time for Wuxi NextCODE to announce the completion of Series C funding.
November 29, 2018

Temasek trims Celltrion stake despite stock slump

Singapore’s sovereign wealth fund pares down its stake in South Korea's leading biologic drug maker for the second time this year as it continues to restructure its investment portfolio.
October 23, 2018

Innovent Biologics’ HK IPO sells long-term value

The drug developer will be the second biotech firm to list in Hong Kong without any profits or revenues. It believes that China’s underpenetrated biologics market provides a massive opportunity in the long run.
October 18, 2018

Sunny spells but no vacation for Asian bond markets

Asian bond markets have been staging an unexpected recovery as fund flows turn positive and investors begin putting money back to work. Can it last as Sino-US trade tensions take centre stage once more?
August 05, 2018